We are international
Donate
• about myeloma TEXT SIZE   
Ask Dr Durie

ask_dr_durie_banner

 

Have a question? Submit it to AskDrDurie@myeloma.org!
 

facebook
googleplus
twitter
youtube


IMF Chairman and Co-Founder Brian G.M. Durie, MD welcomes your questions about the latest myeloma treatments, research, controversies and quality of life issues. If you have a question you think might be of interest to the myeloma community, please send to askdrdurie@myeloma.org! For questions of a specific personal nature, please call the IMF InfoLine coordinators at 800.452.2873 or email them at infoline@myeloma.org.

Our archives are brimming with useful information directed at - and asked by - patients, caregivers, and other interested parties... so please watch the episodes below, and share them as much as possible so that others may benefit!


 

 

 

#Ask Dr. Durie
previous     next      view all

11.12.15   What is Ixazomib?

In this week's video, Dr. Brian Durie the new oral proteasome inhibitor ixazomib.

Bottom Line:
It will be very good for patients if ixazomib is as valuable as currently available drugs


11.05.15   Can DDT exposure cause myeloma?

In this week's video, Dr. Brian Durie answers the question if the insecticide DDT can cause myeloma?

Bottom Line:

We need to understand better how to prevent toxic exposure as another means of preventing myeloma


10.29.15   Can you help make sense of statistics?

In this week's video, Dr. Brian Durie helps make sense of the numbers and statistics in relation with your myeloma diagnosis and treatment.

Bottom Line:

The IMF will be a resource to help educate patients about statistics


10.22.15   What does it mean to be MRD-negative if you have high-risk 17p- myeloma?

In this week's video, Dr. Brian Durie discusses the implications of being MRD-negative if you have high-risk 17p- myeloma.

Bottom Line:

Testing will hopefully lead to improved therapies for patients with 17p- myeloma.


10.01.15   Do bone lesions regenerate?

In this week's video, Dr. Brian Durie answers the question do bone lesions regenerate.

Bottom Line:

Bones don't heal back to normal, but there are ways to recover functionality.


09.24.15   Do African Americans have an increased risk of myeloma?

In this week's video, Dr. Brian Durie discusses the question if African Americans have an incresed risk of myeloma.

Bottom Line:

Since African American are at higher risk for myeloma yet respond better to treatment, early diagnosis is the key. 


09.17.15   How does the IMF help accelerate new drug approvals?

In this week's video, Dr. Brian Durie answeres the question on how the International Myeloma Foundation contributes to the acceleration of new drug approvals for multiple myeloma.

Bottom Line:

The IMF's work helps expedite the progress of new drugs from trial phase to full approval.


09.10.15   Are statins helpful or harmful for myeloma patients?

In this week's video, Dr. Brian Durie answers the question regarding statins and its effect on myeloma patients.

Bottom Line:

Myeloma patients need to be cautious when taking statins...But not overly concerned about their impact on the myeloma itself.


09.03.15   What is the role of imaging for routine assessment of myeloma?

In this week's video, Dr. Brian Durie answers a patient's question regarding the importance of imaging and other tests in the routine assessment of myeloma.

Bottom line:

Set an imaging protocol, get a baseline scan and a periodic re-check.


08.27.15   What is the latest news about the Black Swan Research Initiative?

In this week's video, Dr. Brian Durie gives an update on the IMF's signature research project, Black Swan Research Initative.

Bottom Line:

The BSRI team is expanding worldwide and exciting progress is being made.


previous     next      view all